Celltrion
068270.KS
#810
Rank
NZ$49.60 B
Marketcap
NZ$220.58
Share price
2.07%
Change (1 day)
14.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

ESG Reports

Thumbnail Celltrion
 ESG Report 2023-2024

ESG Report 2023-2024

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2022-2023

ESG Report 2022-2023

Language: English

View ESG Report